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Intraoperative floppy iris syndrome (IFIS) is a complication due to 
cataract surgery and has been linked to the use of systemic therapy with 
alpha-1 blocker drugs, especially tamsulosin. The appearance of its 
symptoms makes the cataract operation itself complicated in every step. The 
aim of this study was to demonstrate the efficacy of Malyugin pupillary 
dilator in dealing with IFIS symptoms. The study involved 40 untreated and 
40 treated patients with Malyugin ring intraoperatively. In each patient the 
following parameters were evaluated: pre- and postoperative best corrected 
visual acuity (BCVA), intraoperative and postoperative pupillary diameter, 
as well as intraoperative and postoperative complications Intraoperative and 
postoperative complications were significantly more prevalent in the 
untreated than in the treated group. This study suggests that Malyugin ring is 
effective in dealing with IFIS symptoms in patients undergoing tamsulosin 
therapy. 
 





                                                            






Intraoperative floppy iris syndrome (IFIS) is an intraocular change which 
is linked with higher risk of complications during cataract surgery. Starting 
15 years ago, when IFIS was described for the first time by Chang and 
Campbell1, to the present day, it has kept the attention of cataract surgeons 
and it is a challenge to deal with its features. In order to recognize IFIS, the 
surgeon must know its clinical signs: the presence of flaccid iris, its prolapse 
through scleral intraoperative incisions, and progressive miosis of the eye's 
pupil despite the use of standard preoperative therapy.2 The presence of these 
clinical signs obstructs the cataract surgery, leading to a higher incidence of 
complications.3 
The occurrence of this syndrome is very often associated with the use of 
any drug from the group of alpha-1 blockers, but most often occurs with the 
use of the drug tamsulosin.4 Among the indications for tamsulosin therapy, 
its most common use is in the treatment of benign prostatic hyperplasia 
(BPH) in men. This disease occurs in about 50% of men aged 51 to 60 years, 
and in about 80% of men over the age of 80.5  
 
PATIENTS AND METHOD 
 
In this study, there are 80 eyes i.e 80 patients diagnosed with cataracts, all 
men, with systemic therapy with tamsulosin and without a medical history 
for another ophthalmic disease. To make the desired comparison, we divided 
the patients into two groups: the first group was our control group and 
included 40 patients in whom no mechanical pupillary dilator was used 
intraoperatively, and the second group included another 40 patients in whom 
Malyugin pupillary dilator was used intraoperatively.  
Preoperatively, we informed all patients about the course, possible 
complications and the expected outcome of the cataract surgery. A complete 
ophthalmological examination, an internist examination, as well as a 
complete blood count test with sedimentation rate was performed in all 
patients. The complete ophthalmological examination included: 
determination of the best corrected visual acuity (BCVA) on the Snellen 
board with a SCHIN-NIPONN phoropter, measurement of intraocular 
pressure with a non-contact Huvitz tonometer, a detailed examination of the 
anterior segment with a spatula lamp (if the medium was transparent), as 
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well as a detailed examination of the posterior segment also with a split 
lamp, A-scan and/or B-scan with PIROP - Ophthalmic Scanner (A + B + 
CCT) and an OCT imaging with Cirrus HD OCT 4000 Zeiss (if the medium 
was transparent). 
We used tropicamide (Mydriacyl 0.5%) preoperatively and 
intraoperatively lidocaine, hyalon 5 (viscoelastic), and adrenaline when the 
action of tropicamide was insufficient, to achieve the desired mydriasis of 6-
7 mm. 
We noted the pre- and intraoperative dimensions of the pupillary 
diameter. Preoperative pupillary dimensions were measured with Atlas 900 
Zeiss, i.e intraoperatively with Rosenbaum cards and Colvard pupilometer. 
Phacoemulsification cataract surgery was performed with Zeiss OPMI 
Lumera operating microscope and Bausch Lomb Stellaris cataract surgery 
device. 
We analyzed both intra and postoperative complications, the best 
corrected postoperative visual acuity according to the Snellen board, and 
postoperative intraocular pressure values. 
There were performed two follow-ups, in 24 hours and in 30 days after 
cataract phacoemulsification surgery. 




The preoperative dimensions of the pupillary diameter in the two 
examined groups were ranged from 2.5mm to 6.5mm, with an average of 






















Група 1 1 3 3 5 9 9 8 2 40 
Група 2 1 1 1 4 8 7 16 2 40 
Вкупно 2 4 4 9 17 16 24 4 80 
Table 1. Preoperative dimensions of pupillary diameter 
Group 1: patients in whom Malyugin ring was not used 




The intraoperative dimensions of the pupillary diameter in patients in the 
control group were ranged from 2.5 mm to 4.0 mm, with an average of 3.04 





Група 1 11 
Група 2 10 
Вкупно 21 
Table 2. Final intraoperative dimensions of pupillary diameter
 
While in patients from the 
dilator was used intraoperatively, mydriasis of 6
application of the dilator, which is crucial for the successful course of 
cataract surgery. 
As a measure of the success of cataract surgery in patients w
occurrence of intra and postoperative complications, which were analyzed 
on two independent graphs in the control and study groups. The following 
intraoperative complications were noted in the control group: 18 patients had 
iris prolapse, 1 patient 
capsule rupture as the most severe complication of cataract surgery (
1). 
Graph 1. Intraoperative complicati
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The following postoperative 
group: 9 patients had a sphincter rupture, 8 patients had a transilluminal 
defect, while 2 patients had a sphincter rupture and a transluminal defect 
combined (Graph 2). 
 
Graph 2. Postoperative complications 
tamsulosin therapy and mechanical dilators were not used while 
Contrary to the data obtained from patients in the control group, in 
patients in whom we used Malyugin pupillary dilat
study group), there were
complications, only 5 patients had a transilluminal defect, which occurred as 
a result of ring migration during 
Preoperative best-correcte
ranged from 0.2 to 0.4, with an average of 0.3 according to the Snellen chart 
(Table 3). 
The postoperative best corrected visual acuity of the operated eye in 
patients in the control group was on average 
group was 0.9 according to the Snellen board, indicating a small but 
insignificant decrease in vision in 
Intraocular pressure values 
ranged from 16 to 24 mmHg, averaging 20.73 mmHg (Table 3).
There is no significant difference in BCVA preoperative values, 
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Mean value 74.8 0.3 0.8 20.69 5.07 3.05 0.55 0.46 
Standard 
deviation 





 Mean value 74.48 0.28 0.9 20.76 5.39 3.04 0 0.13 
Standard 
deviation 
5.65 0.08 0.07 2.17 0.83 0.45 0 0.33 
Student t-test (p value) >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 <0.05 <0.05 
BCVA (preoperative) - Preoperative best corrected visual acuity, BCVA 
(postoperative) - Postoperative best corrected visual acuity, Prepop. 
mydriasis - preoperative dimensions of pupillary diameter; Intraop. 
mydriasis - final intraoperative dimensions of pupillary diameter; IOP - 
intraocular pressure in the first postoperative day. 
Table 3. Statistical data processing, calculated standard deviation 
and Student t-test for patients from both groups 
 
Figure 1 shows an already applied Malyugin ring. 
 
 




Intraoperative floppy iris syndrome (IFIS) is a clinical syndrome found in 
cataract surgery in patients receiving systemic therapy with alpha-1 blockers, 
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especially tamsulosin, which is used in treatment of benign prostatic 
hyperplasia. The expression of clinical symptoms in this syndrome is 
variable in different patients, and may even differ between the two eyes in 
the same patient. We distinguish three clinical forms of IFIS depending on 
the severity of the symptoms:6 
- Mild form, where there is intraoperative mydriasis of 6mm or more, 
with minimal iris tremor; 
- Moderate form, where there is a moderately dilated pupil 
intraoperatively and there is a moderate tendency of the iris to prolapse 
through surgical scleral incisions; 
- Severe form, where there is progressive intraoperative miosis resistant 
to standard preoperative therapy for its prevention, and as a consequence 
more serious complications occur, such as rupture of the posterior capsule 
and prolapse of the vitreous in the anterior chamber. 
Tamsulosin is the first licensed alpha-1 blocker (1997) to treat benign 
prostatic hyperplasia.7 Its main mechanism of action is relaxation of the 
smooth muscles of the prostate and bladder through selective inhibition of 
alpha-1 adrenoreceptors, but because these receptors are also present in large 
numbers in the iris dilator muscle, secondarily leads to the occurrence of 
IFIS.8 The exact pathophysiology of this syndrome is not fully understood. 
Equilibrium between pupillary constriction and dilatation occurs by default 
by interaction between alpha and beta-adrenergic receptors and the 
cholinergic system, with the alpha-1A adrenergic receptor being the most 
abundant receptor in the iris that mediates pupillary dilatation.9,10 In addition 
the alpha-1 receptor is the most common adrenergic receptor in the small 
arterioles of the iris, and although not completely confirmed, their inhibition 
results in changes in local blood flow that contribute to pathological changes 
in the iris.11,12 In one of the first studies, Prata and co-workers studied 27 
patients treated with tamsulosin and 22 untreated patients as a control group 
using slit-lamp-adapted optical coherence tomography (SL-OCT). They 
observed a significant reduction in iris dilator muscle thickness in patients 
treated with tamsulosin (P = 0.001) compared with patients in the control 
group. In a recent study, with optical microscopy were examined 14 eyes 
removed after death of patients previously treated with tamsulosin and 
compared with samples taken from the eyes of untreated patients in a control 
group.14 Mean iris dilator muscle thickness was significant decreased in 
patients treated with tamsulosin compared with patients in the control group 
(P = 0.004), with no marked differences in iris stroma. Reduced myofibrils 
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and enlarged vacuoles have been observed on transmission electron 
microscopy (TEM), and such findings link iris dilator muscle atrophy to 
treatment with this alpha-blocker.14 
Surprisingly, patients who received very small doses of tamsulosin were 
also at increased risk of developing IFIS. A study by Chang et al. showed 
that discontinuation of tamsulosin therapy 1 to 8 weeks before cataract 
surgery did not result in a change in the severity of IFIS symptoms, but 
resulted in greater mydriasis of the papilla at the onset of surgery.15 It has 
also been shown that even 1 year of discontinuation of tamsulosin does not 
prevent the development of IFIS.1 There are studies showing that symptoms 
of IFIS may appear even after several years of discontinuation of tamsulosin 
therapy.16 
In addition to understanding the pathophysiology of this syndrome, it is 
important to learn how to prevent and how to deal with the symptoms and 
consequences of IFIS. There are studies in which the authors have tried to 
replace tamsulosin with another alpha blocker preoperatively, but because 
the changes caused by tamsulosin are long-term, this attempt has proved 
unsuccessful.17 Several authors have tried to find a solution to this problem, 
such as Chadha V., Borooah S. and Tey A.18, then Chan DG. and Francis19, 
Gurbaxani A. and Packard R.20, as well as Masket S. and Belani S.21, but 
unfortunately none of these proposals have proved effective enough. If the 
pupil is stretched with a spatula or a Kuglen hook, it can easily cause iris 
bleeding. Then the technique of applying the iris hooks in diamond 
configuration was presented, but even in this way the sphincter can rupture 
and the iris can bleed. Asia Pupil Expander recently introduced a new way of 
applying a square iris hook in the form of scissors, but the disadvantage is 
that two additional intraoperative incisions must be made to use this 
method.22 
In our study, we found that in patients who were under tamsulosin 
therapy and mechanical dilators were not used while operating were more 
likely to have complications, with the most severe complication being a 
posterior capsule rupture. One of the most common complications that 
greatly complicated cataract surgery was intraoperative iris prolapse, which 
was completely avoided in the treatment group in which Malyugin pupillary 
dilator was used. 
Although intra and postoperative complications were observed in the 
control group, there was no difference in the postoperative results of BCVA 




Advantages of Malyugin pupillary dilator are:23 
1. It has a square shape, with 4 circular scrolls and 8 fixing points that 
allow an even circular opening of the pupil. 
2. The dilator itself gently opens the iris thus eliminating the risk of 
damage. The latest version of the Malyugin dilator is made of 5.0 
polypropylene. 
3. The diameter of the dilator is from 6.25 to 7.0mm, i.e it can be applied 
through the main scleral incision of 2.0mm, so no additional intraoperative 
incisions are needed. 
4. It is designed to have minimal contact with the iris during its 
application and extraction, i.e it is inserted and removed with a special 
injector. 





Patients receiving systemic tamsulosin therapy are at risk of developing 
IFIS symptoms, which contribute to difficulties in performing cataract 
surgery with phacoemulsification, and thus increase the risk of intra and 
postoperative complications. However, in this study, there were no 
intraoperative or postoperative complications in patients with IFIS in whom 
Malyugin ring was applied. This study suggests that Malyugin ring is an 
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